Keeping in line with the idea that AD involves a “progressive, smoldering inflammation of the brain”, several independent research laboratories have described specific increases in the abundance and/or activity of the transcription factor NF-κB in AD affected tissues [57,58,59,60,61,62,64,65,66,67,76]. This evidence concerns the gene NFKB1 and Alzheimer disease.